ANGLE PLC ADR ANPCY
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ANPCY is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $1.80
- Day Range
- $1.89–1.89
- 52-Week Range
- $1.13–4.00
- Bid/Ask
- $1.18 / $2.09
- Market Cap
- $49.25 Mil
- Volume/Avg
- 495 / 1,290
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.41
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
ANGLE PLC is active in the healthcare sector in the United Kingdom. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which majority of its revenue is generated from Europe.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Growth
- Total Number of Employees
- 165
- Website
- https://www.angleplc.com
Valuation
|
Metric
|
ANPCY
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 1.49 |
Price/Sales | 22.41 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ANPCY
|
|---|---|
Quick Ratio | 6.93 |
Current Ratio | 7.51 |
Interest Coverage | −69.57 |
Quick Ratio
ANPCY
Profitability
|
Metric
|
ANPCY
|
|---|---|
Return on Assets (Normalized) | −39.99% |
Return on Equity (Normalized) | −59.91% |
Return on Invested Capital (Normalized) | −44.24% |
Return on Assets
ANPCY
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Rpzhdtsh | Ctt | $206.7 Bil | |
DHR
| Danaher Corp | Wcgfnyhqbn | Cbqcdk | $175.0 Bil | |
IQV
| IQVIA Holdings Inc | Wfkcfqy | Pmlzqg | $41.3 Bil | |
IDXX
| IDEXX Laboratories Inc | Tpmxvdjy | Gqyfwpk | $39.7 Bil | |
A
| Agilent Technologies Inc | Xlmydkwsc | Fwlvv | $38.8 Bil | |
MTD
| Mettler-Toledo International Inc | Wqhbbkpqz | Gzftnx | $25.5 Bil | |
ICLR
| Icon PLC | Rmvmjcmt | Xqkdwv | $24.1 Bil | |
ILMN
| Illumina Inc | Ryrgfndj | Nxjwcg | $18.6 Bil | |
WAT
| Waters Corp | Ykztypkj | Tsgfz | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Vhctkgfstx | Vkdfvr | $16.8 Bil |